PolarityTE™ Announces a New 200,000 sq ft Polarity Campus and Corporate Headquarters to Meet the Demand for SkinTE™ and A...
December 20 2017 - 8:30AM
PolarityTE, Inc. (NASDAQ:COOL) today officially announced that the
company has continued to expand its R&D and biomedical
manufacturing capabilities and moved its corporate headquarters to
a 200,000 ft2 multi-facility “PolarityTE Campus.”
Slated to open in early 2018, the new Polarity
corporate campus will centralize core company departments related
to basic biomedical R&D, pre-clinical research, as well as
provide another site for the manufacturing of the now commercially
available SkinTE™ product. The campus will also house the “TE”
development hub for the Company’s pipeline of products and
technology derivatives of which OsteoTE™ is set for expected
commercialization in late 2018.
“With the expansive addition of the new PolarityTE
campus, we hope to meet the impressive demand we have already
received for SkinTE, while allowing us to grow our company, develop
our core pipeline tissues and further evolve our technology
platforms at an even more accelerated rate,” said Dr. Denver Lough,
Chief Executive Officer of PolarityTE. “Our newly integrated
headquarters and manufacturing facilities underscores PolarityTE’s
commitment to growing our commercial operations and capabilities
nationally, as well as our continued dedication to the development
of pragmatic biomedical technologies and regenerative
materials.”
About PolarityTE™PolarityTE, Inc.
is a regenerative medicine company, with a platform technology to
regenerate full-thickness tissue. The Company's novel regenerative
medicine platform and proprietary technology employs a patient's
own cells for the healing of full-thickness, functionally-polarized
tissues. If clinically successful, the PolarityTE™ platform will
provide medical professionals with a truly new paradigm in wound
healing and reconstructive surgery by utilizing a patient's own
tissue substrates for the regeneration of skin, bone, muscle,
cartilage, fat, blood vessels and nerves. The PolarityTE™ platform
leverages natural and biologically-sound principles which are
readily adaptable to a wide spectrum of organ and tissue systems.
This revolutionary technology, paired with the Company's
world-renowned clinical advisory board, position PolarityTE™ to
drastically change the field and future of translational
regenerative medicine. More information can be found online
at www.PolarityTE.com.
Forward Looking StatementsCertain
statements contained in this release are "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward looking statements contained in this
release relate to, among other things, the Company's ongoing
compliance with the requirements of The NASDAQ Stock Market and the
Company's ability to maintain the closing bid price requirements of
The NASDAQ Stock Market on a post reverse split basis. They are
generally identified by words such as "believes," "may," "expects,"
"anticipates," "should'" and similar expressions. Readers should
not place undue reliance on such forward-looking statements, which
are based upon the Company's beliefs and assumptions as of the date
of this release. The Company's actual results could differ
materially due to risk factors and other items described in more
detail in the "Risk Factors" section of the Company's Annual
Reports and other filings with the SEC (copies of which may be
obtained at www.sec.gov). Subsequent events and developments may
cause these forward-looking statements to change. The Company
specifically disclaims any obligation or intention to update or
revise these forward-looking statements as a result of changed
events or circumstances that occur after the date of this release,
except as required by applicable law.
Investor ContactJohn
StetsonInvestorRelations@PolarityTE.com(385) 237-2365
Media ContactsScott SantiamoRusso
Partners LLCScott.Santiamo@RussoPartnersLLC.com (718)
344-5843David SchullRusso Partners
LLCDavid.Schull@RussoPartnersLLC.com (858) 717-2310
Corner Growth Acquisition (NASDAQ:COOL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Corner Growth Acquisition (NASDAQ:COOL)
Historical Stock Chart
From Sep 2023 to Sep 2024